[Psychiatric complications of medicines].
Otsubo
Tempei
T
Department of Psychiatry, Showa University School of Medicine.
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000928:Antidepressive Agents / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000008:administration & dosage; D002492:Central Nervous System Depressants / Q000009:adverse effects; D005938:Glucocorticoids / Q000009:adverse effects; D006635:Histamine H2 Antagonists / Q000009:adverse effects; D006801:Humans; D007372:Interferons / Q000009:adverse effects; D001523:Mental Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D014150:Antipsychotic Agents; D002492:Central Nervous System Depressants; D005938:Glucocorticoids; D006635:Histamine H2 Antagonists; D007372:Interferons; D017367:Selective Serotonin Reuptake Inhibitors